HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Medial epiphysiolysis in severe infantile tibia vara.

Abstract
Recurrent varus deformity and shortening frequently result following valgus osteotomy alone for advanced stage infantile tibia vara (ITV), due to the proximal medial physeal dysfunction which resembles a complete growth arrest in Langenskiöld grade III or greater lesions. Epiphysiolysis is a possible treatment alternative which, if successful, can restore symmetric proximal tibial growth and obviate the need for additional complex treatments to address recurrent angular deformity and limb length inequality. We reviewed 24 patients, ages 5-10 years, with 27 affected tibiae, who underwent epiphysiolysis of the proximal medial tibia combined with valgus osteotomy. The procedure was >80% successful in restoring growth and avoiding varus recurrence in children <7 years old. Patients >age 7, patients with relative undercorrection of their mechanical axis at the time of surgery, and patients with previous failed surgical treatment were more likely not to benefit from epiphysiolysis, and consequently alternative methods may be more appropriate.
AuthorsNicholas Andrade, Charles E Johnston
JournalJournal of pediatric orthopedics (J Pediatr Orthop) 2006 Sep-Oct Vol. 26 Issue 5 Pg. 652-8 ISSN: 0271-6798 [Print] United States
PMID16932107 (Publication Type: Journal Article)
Chemical References
  • Bone Cements
  • Methylmethacrylate
Topics
  • Bone Cements (therapeutic use)
  • Child
  • Child, Preschool
  • Epiphyses (growth & development, surgery)
  • Female
  • Humans
  • Joint Deformities, Acquired (surgery)
  • Male
  • Methylmethacrylate (therapeutic use)
  • Orthopedics (methods)
  • Prostheses and Implants
  • Retrospective Studies
  • Tibia (abnormalities, growth & development)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: